These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7872848)

  • 1. Considering neuroleptic maintenance and taper on a continuum. Need for individual rather than dogmatic approach.
    Jeste DV; Gilbert PL; McAdams LA; Harris MJ
    Arch Gen Psychiatry; 1995 Mar; 52(3):209-12. PubMed ID: 7872848
    [No Abstract]   [Full Text] [Related]  

  • 2. Why neuroleptic withdrawal in schizophrenia?
    Carpenter WT; Tamminga CA
    Arch Gen Psychiatry; 1995 Mar; 52(3):192-3. PubMed ID: 7872843
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic withdrawal in schizophrenic patients.
    Baldessarini RJ; Viguera AC
    Arch Gen Psychiatry; 1995 Mar; 52(3):189-92. PubMed ID: 7872842
    [No Abstract]   [Full Text] [Related]  

  • 4. Risks of withdrawing antipsychotic medications.
    Wyatt RJ
    Arch Gen Psychiatry; 1995 Mar; 52(3):205-8. PubMed ID: 7872847
    [No Abstract]   [Full Text] [Related]  

  • 5. The early course of schizophrenia and long-term maintenance neuroleptic therapy.
    Nuechterlein KH; Gitlin MJ; Subotnik KL
    Arch Gen Psychiatry; 1995 Mar; 52(3):203-5. PubMed ID: 7872846
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic discontinuation and tardive dyskinesia risk.
    Sherr JD; Medoff D; Thaker G
    Am J Psychiatry; 1999 Jul; 156(7):1125-6. PubMed ID: 10401483
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
    Gilbert PL; Harris MJ; McAdams LA; Jeste DV
    Arch Gen Psychiatry; 1995 Mar; 52(3):173-88. PubMed ID: 7872841
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come.
    Meltzer HY
    Arch Gen Psychiatry; 1995 Mar; 52(3):200-2. PubMed ID: 7872845
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of tardive dyskinesia.
    Raja M
    Schweiz Arch Neurol Psychiatr (1985); 1996; 147(1):13-8. PubMed ID: 8685689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment for lifetime disorders?
    Greden JF; Tandon R
    Arch Gen Psychiatry; 1995 Mar; 52(3):197-200. PubMed ID: 7872844
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe extrapyramidal side effects when discontinuing clozapine and starting haloperidol.
    Bobba R
    Can J Psychiatry; 1997 Jun; 42(5):530. PubMed ID: 9220119
    [No Abstract]   [Full Text] [Related]  

  • 12. [Withdrawal symptoms of neuroleptics?].
    Mager T
    Med Monatsschr Pharm; 1994 Aug; 17(8):252. PubMed ID: 7935155
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychotic recurrence after antipsychotic discontinuation.
    Zipursky RB
    Am J Psychiatry; 2002 Aug; 159(8):1441-2; author reply 1442. PubMed ID: 12153856
    [No Abstract]   [Full Text] [Related]  

  • 14. Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesia.
    Diamond BI; Borison RL
    Psychopharmacol Bull; 1986; 22(3):900-5. PubMed ID: 2879312
    [No Abstract]   [Full Text] [Related]  

  • 15. [The risk of neuroleptic discontinuation in schizophrenia].
    Jarema M
    Psychiatr Pol; 1999; 33(1):69-81. PubMed ID: 10786216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
    Ben Hadj Ali B; Dogui M; Ben Ammou S; Lôo H
    Encephale; 1995; 21(3):209-15. PubMed ID: 7649071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic-induced supersensitivity psychosis, the "hump course," and tardive dyskinesia.
    Chovinard G; Jones B
    J Clin Psychopharmacol; 1982 Apr; 2(2):143-4. PubMed ID: 6122695
    [No Abstract]   [Full Text] [Related]  

  • 18. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN; Inamdar A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complications of drug withdrawal from antiparkinson agents and neuroleptics].
    Mizon JP; Rosa A
    Therapie; 1984; 39(4):421-5. PubMed ID: 6148792
    [No Abstract]   [Full Text] [Related]  

  • 20. The concept of supersensitivity psychosis.
    Kirkpatrick B; Alphs L; Buchanan RW
    J Nerv Ment Dis; 1992 Apr; 180(4):265-70. PubMed ID: 1348269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.